Stay updated on ARO-C3 in Renal Disease Clinical Trial
Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page
- Check5 days agoChange DetectedAdded 'IgA glomerulonephritis' to the list of conditions on the study page.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded 'Complement 3 glomerulopathy' as a condition term and removed 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis' from the disease terminology.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page now shows a revision note for v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page adds a disease term 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis' and a Genetic and Rare Diseases Information Center resource, and deletes an old funding notice and revision note. These updates are informational and do not alter the study's design or displayed results.SummaryDifference0.6%

- Check62 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center operating status. Updated page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.